Medicare Enrolled

Dr. Arshia Sadreddin

Neurology · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2100 WEBSTER ST STE 115, San Francisco, CA 94115
4156007886
In practice since 2007 (18 years)
NPI: 1033308903 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sadreddin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sadreddin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sadreddin

Dr. Arshia Sadreddin is a neurology specialist in San Francisco, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Sadreddin performed 695 Medicare services across 399 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sadreddin received a total of $106,081 from 34 pharmaceutical and/or device companies across 328 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sadreddin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 39% volume in CA $106,081 industry payments

Medicare Practice Summary

Medicare Utilization ↗
695
Medicare services
Top 39% in CA for neurology
399
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
386 $162 $489
Brain stimulator programming, additional 15 minutes
Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service.
97 $40 $194
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
59 $29 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
47 $115 $364
Brain stimulator programming, first 15 minutes
Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes.
45 $45 $220
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
26 $17 $288
New patient office visit, complex (60-74 min) 20 $199 $697
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $157 $704
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$106,081
Total received (2018-2024)
Avg $15,154/year across 7 years
Top 6% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
328
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$83,000 (78.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16,419 (15.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,662 (6.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,146
2023
$8,164
2022
$20,707
2021
$22,570
2020
$16,086
2019
$25,269
2018
$11,140

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amneal Pharmaceuticals LLC
$1,425
Boston Scientific Corporation
$291
ABBVIE INC.
$188
Medtronic, Inc.
$106
Abbott Laboratories
$57
Neurocrine Biosciences, Inc.
$55
Acorda Therapeutics, Inc
$24
Top 3 companies account for 88.7% of 2024 payments
All-time payments by company (2018-2024) ›
Neurocrine Biosciences, Inc.
$51,405
Acorda Therapeutics, Inc
$27,926
Neurocrine BioSciences, Inc.
$11,130
Boston Scientific Corporation
$8,370
BOSTON SCIENTIFIC CORPORATION
$1,795
Amneal Pharmaceuticals LLC
$1,442
Medtronic USA, Inc.
$1,108
Medtronic, Inc.
$459
Avanir Pharmaceuticals, Inc.
$248
Lundbeck LLC
$220
Adamas Pharmaceuticals, Inc.
$219
Teva Pharmaceuticals USA, Inc.
$211
ABBVIE INC.
$208
Allergan Inc.
$176
UCB, Inc.
$170
US WorldMeds, LLC
$107
Bausch Health US, LLC
$100
SK Life Science, Inc.
$93
LivaNova USA, Inc.
$85
Abbott Laboratories
$73
AbbVie Inc.
$70
Eisai Inc.
$69
Amgen Inc.
$67
Sunovion Pharmaceuticals Inc.
$43
Lilly USA, LLC
$43
Novartis Pharmaceuticals Corporation
$43
Impax Laboratories, Inc.
$38
Kyowa Kirin, Inc.
$38
Allergan, Inc.
$34
Biohaven Pharmaceuticals, Inc.
$24
GE Healthcare
$21
AQUESTIVE THERAPEUTICS, INC.
$20
Greenwich Biosciences, Inc.
$16
Supernus Pharmaceuticals, Inc.
$12
Top 3 companies account for 85.3% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AIMOVIG · AJOVY · APOKYN · AUSTEDO · Aimovig · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · Briviact · CREXONT · DUOPA · EMGALITY · Epidiolex · Fycompa · GENERAL DBS · GENERAL - DBS · GENERAL DBS · GOCOVRI · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KYNMOBI · MIGRANAL · NORTHERA · NOURIANZ · NUEDEXTA · NURTEC ODT · Neupro · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · Ongentys · PERCEPT PC BRAINSENSE · RYTARY · SYMPAZAN · SureTek · TROKENDI XR · VERCISE · VNS Therapy · VYALEV · Vercise · Xadago
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in CA.

Looking for a neurology specialist in San Francisco?
Compare neurologists in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
245
Per 100K population
29.3
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sadreddin is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 6% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sadreddin experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Sadreddin performed 386 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sadreddin receive payments from pharmaceutical companies?
Yes. Dr. Sadreddin received a total of $106,081 from 34 companies across 328 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sadreddin's costs compare to other neurologists in San Francisco?
Dr. Sadreddin's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sadreddin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →